Champions Oncology to Exhibit at AACR-NCI-EORTC
Hackensack, NJ – November 2, 2015 – Champions Oncology, Inc., (CSBR) a company engaged in the development of advanced oncology solutions and services to personalize the development and use of oncology drugs, today announced the company will be attending and exhibiting at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics taking place November 5-9, in Boston, MA. Members of the scientific and bioinformatics teams will also present during poster sessions.
Posters will be presented during Poster Session A on Friday, November 6 from 12:15pm – 3:15pm.
- The ImmunoGraft : a humanized mouse model for translational assessment of immunotherapy in solid tumors. (Poster A8)
- Molecular fidelity of patient-derived xenograft (PDX) models to original human tumor and to the cancer genome atlas (Poster A14)
Champions Oncology will be exhibiting at booth 606.